In a surprise twist, 23andMe founder and former CEO Anne Wojcicki is set to regain control of the DNA company's assets, according to a press release from 23andMe. In May, a company called Regeneron bought 23andMe for $256 million in a bankruptcy auction, but Wojcicki's nonprofit, TTAM Research Institute, was able to reopen bidding with an "unsolicited offer" of $305 million, The Wall Street Journal reports.<br /> A bankruptcy judge agreed to reopen bidding on 23andMe under the condition that Regeneron top Wojcicki's proposed price by at least $10 million, according to WSJ. Regeneron declined, leaving 23andMe in TTAM's control assuming the judge approves the deal. A hearing to consider the new deal is set for June 17, 2025.<br /> Regeneron had previ [...]
DNA testing company 23andMe has filed for Chapter 11 bankruptcy, following a tumultuous few years that included significant layoffs and a wide-ranging data breach. It plans to find a buyer and continu [...]
23andMe (ME) on Sunday filed for bankruptcy protection after struggling to combat weak demand for its DNA testing kit and the fallout of a data breach that effected millions of customers. Read more... [...]
Genetic testing company 23andMe (ME) filed for bankruptcy protection Sunday in the latest stage of a rocky road that included weak consumer demand and a 2023 data breach that jeopardized the genetic d [...]
Novo Nordisk is expanding its cash-only savings program offering its blockbuster weight-loss drug Wegovy for $499 a month at all U.S. pharmacies. 23andMe has filed for Chapter 11 bankruptcy protection [...]
San Francisco-based 23andMe, which sells at-home DNA testing kits, has filed for bankruptcy in the US and is looking for a new buyer — heightening concerns about the personal data of millions of peo [...]